UBS Group
BHACW

UBS Group’s Barington/Hilco Acquisition Corp. Warrants BHACW Stock Holding History

UBS Group’s Portfolio BHACW Stock Details BHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,970
Closed – – 8653
2018
Q3 		$0 Buy
6,970
+400
+6% +$53 ﹤0.01% 8525
2018
Q2 		$1K Hold
6,570
– – ﹤0.01% 7909
2018
Q1 		$1K Buy
6,570
+2,982
+83% +$652 ﹤0.01% 7729
2017
Q4 		$0 Sell
3,588
-6,724
-65% -$553 ﹤0.01% 8311
2017
Q3 		$1K Buy
10,312
+1,352
+15% +$191 ﹤0.01% 7642
2017
Q2 		$1K Buy
8,960
+2,010
+29% +$293 ﹤0.01% 7577
2017
Q1 		$1K Sell
6,950
-1,950
-22% -$276 ﹤0.01% 7527
2016
Q4 		$1K Buy
8,900
+8,600
+2,867% +$720 ﹤0.01% 7686
2016
Q3 		$0 Buy
+300
New +$32 ﹤0.01% 8146

UBS Group's BHACW Position: Q4 2018 in Review

UBS Group sold out of Barington/Hilco Acquisition Corp. Warrants (BHACW) in Q4 2018, closing a stake of 6,970 shares.

UBS Group first reported a position in BHACW in Q3 2016 and held it in 9 quarters. The position peaked at $1K in Q2 2018. 0 funds tracked by Wall St. Rank hold BHACW as of Q4 2018.

  • UBS Group reported no remaining Barington/Hilco Acquisition Corp. Warrants position as of Q4 2018 after selling out during the quarter.
  • UBS Group sold 6,970 Barington/Hilco Acquisition Corp. Warrants shares in Q4 2018.
  • UBS Group first reported a position in Barington/Hilco Acquisition Corp. Warrants in Q3 2016 and held it in 9 quarters.
  • UBS Group's Barington/Hilco Acquisition Corp. Warrants position peaked at $1K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Barington/Hilco Acquisition Corp. Warrants as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.